Jing Hu

2.1k total citations · 1 hit paper
84 papers, 1.3k citations indexed

About

Jing Hu is a scholar working on Complementary and alternative medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jing Hu has authored 84 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Complementary and alternative medicine, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Jing Hu's work include Traditional Chinese Medicine Studies (13 papers), Meta-analysis and systematic reviews (9 papers) and Clinical practice guidelines implementation (7 papers). Jing Hu is often cited by papers focused on Traditional Chinese Medicine Studies (13 papers), Meta-analysis and systematic reviews (9 papers) and Clinical practice guidelines implementation (7 papers). Jing Hu collaborates with scholars based in China, United States and United Kingdom. Jing Hu's co-authors include Siyan Zhan, Hongcai Shang, Bo Li, Huina Zhang, Guozhen Zhao, Po Huang, Dana Pe’er, Ziwei Wang, Charles M. Rudin and Viola Allaj and has published in prestigious journals such as Nature Medicine, PLoS ONE and Journal of Virology.

In The Last Decade

Jing Hu

78 papers receiving 1.3k citations

Hit Papers

Regenerative lineages and immune-mediated pruning in lung... 2020 2026 2022 2024 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Regenerative lineages and immune-mediated pruning in lung cancer metastasis
    2020 251 citations Ashley M. Laughney, Jing Hu et al. Nature Medicine profile →

Peers

Jing Hu
Xiangli Cui China
Ting Yang China
Zonggui Wu China
Fu-Chao Liu Taiwan
Xiao‐Mei Li China
Xiaowei Zheng China
Xiaoling Yang China
Georgia Vogiatzi Greece
Yuhua Zhang China
Xiangli Cui China
Jing Hu
Citations per year, relative to Jing Hu Jing Hu (= 1×) peers Xiangli Cui

Countries citing papers authored by Jing Hu

Since Specialization
Citations

This map shows the geographic impact of Jing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Hu more than expected).

Fields of papers citing papers by Jing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Hu. The network helps show where Jing Hu may publish in the future.

Co-authorship network of co-authors of Jing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Hu. A scholar is included among the top collaborators of Jing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Hu. Jing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Jing, Jing Wang, Benjamin Chang, et al.. (2024). Bromocriptine mesylate-loaded nanoparticles co-modified with low molecular weight protamine and lactoferrin for enhanced nose-to-brain delivery in Parkinson’s disease treatment. International Journal of Pharmaceutics. 669. 125054–125054. 2 indexed citations
3.
Zhang, Qun, Jie Xiao, Xin Zhang, et al.. (2023). Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells. International Journal of Nanomedicine. Volume 18. 2261–2273. 36 indexed citations
4.
Wang, Xiuzhi, et al.. (2023). A new, alternative risk score for sarcopenia in Chinese patients with type 2 diabetes mellitus. European journal of medical research. 28(1). 165–165. 1 indexed citations
5.
Wu, Dandan, Jiali Wei, Jing Hu, et al.. (2023). A Naïve Phage Display Library-Derived Nanobody Neutralizes SARS-CoV-2 and Three Variants of Concern. International Journal of Nanomedicine. Volume 18. 5781–5795. 5 indexed citations
6.
Zhou, Ding, et al.. (2023). Membrane Trafficking-Related Genes Predict Tumor Immune Microenvironment and Prognosis in Colorectal Cancer. Biochemical Genetics. 62(2). 1413–1427. 2 indexed citations
7.
Hu, Ruixue, et al.. (2022). Tripterygium wilfordii Hook. f. Preparations for Rheumatoid Arthritis: An Overview of Systematic Reviews. Evidence-based Complementary and Alternative Medicine. 2022. 1–18. 4 indexed citations
8.
Xu, Xiaolong, Yadong Yuan, Rongmeng Jiang, et al.. (2022). Effectiveness of Lianhua Qingwen Capsule in Treatment of Asymptomatic COVID-19 Patients: A Randomized, Controlled Multicenter Trial. Journal of Integrative and Complementary Medicine. 28(11). 887–894. 9 indexed citations
9.
Li, Bo, Meng Lv, Guozhen Zhao, et al.. (2021). Clinical Epidemiology in China series. Paper 1: Evidence-based medicine in China: An oral history study. Journal of Clinical Epidemiology. 140. 165–171. 5 indexed citations
10.
Hu, Jing, Shuo Feng, Huina Zhang, et al.. (2021). The Use of Multiple Primary Outcomes in Randomized Controlled Trials of Chinese Herbal Medicine. Evidence-based Complementary and Alternative Medicine. 2021. 1–8. 2 indexed citations
11.
Li, Bo, Bo Nie, Guozhen Zhao, et al.. (2021). Systematic review and pathway enrichment analysis of Chinese medicine in preventing recurrence and improving prognosis of cholelithiasis after gallbladder-preserving lithotripsy. Annals of Palliative Medicine. 10(12). 12985–13001. 6 indexed citations
12.
Laughney, Ashley M., Jing Hu, Nathaniel R. Campbell, et al.. (2020). Regenerative lineages and immune-mediated pruning in lung cancer metastasis. Nature Medicine. 26(2). 259–269. 251 indexed citations breakdown →
13.
14.
Hu, Jing, et al.. (2016). Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis. Frontiers in Pharmacology. 7. 489–489. 14 indexed citations
15.
Hu, Jing, Yan‐Ming Xie, Shu Zheng, Wei Yang, & Siyan Zhan. (2015). Trends in the Use of Guideline-Recommended Medications and In-Hospital Mortality of Patients with Acute Myocardial Infarction in a Chinese Population. PLoS ONE. 10(2). e0118777–e0118777. 4 indexed citations
16.
Lu, Xiao, Jing Hu, Li Zhang, & Hongcai Shang. (2014). Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”. Chinese Journal of Integrative Medicine. 20(7). 510–515. 7 indexed citations
17.
Guo, Liping, Hongcai Shang, Junhua Zhang, et al.. (2010). JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial. Trials. 11(1). 27–27. 28 indexed citations
18.
Hu, Jing. (2009). Rough Ideals in Semirings. 3 indexed citations
19.
Hu, Jing, et al.. (2009). Antidiarrhoeal and intestinal modulatory activities of Wei-Chang-An-Wan extract. Journal of Ethnopharmacology. 125(3). 450–455. 38 indexed citations
20.
Shang, Hongcai, Jing Chen, Junhua Zhang, et al.. (2009). Three therapeutic tendencies for secondary prevention of myocardial infarction and possible role of Chinese traditional patent medicine: viewpoint of evidence‐based medicine. Journal of Evidence-Based Medicine. 2(2). 84–91. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiangli Cui Breakdown of academic impact, for papers by Ting Yang Breakdown of academic impact, for papers by Zonggui Wu Breakdown of academic impact, for papers by Fu-Chao Liu Breakdown of academic impact, for papers by Xiao‐Mei Li Breakdown of academic impact, for papers by Xiaowei Zheng Breakdown of academic impact, for papers by Xiaoling Yang Breakdown of academic impact, for papers by Georgia Vogiatzi Breakdown of academic impact, for papers by Yuhua Zhang
Rankless by CCL
2026